These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20173338)

  • 1. Silencing/overexpressing selected genes as a model of sporadic Parkinson's disease.
    Fishman-Jacob T; Youdim MB; Mandel SA
    Neurodegener Dis; 2010; 7(1-3):108-11. PubMed ID: 20173338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component, SKP1A.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S148-51. PubMed ID: 20082978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
    Fishman-Jacob T; Youdim MBH
    J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S177-9. PubMed ID: 22166427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A.
    Fishman-Jacob T; Reznichenko L; Youdim MB; Mandel SA
    J Biol Chem; 2009 Nov; 284(47):32835-45. PubMed ID: 19748892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SKP1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Neurodegener Dis; 2012; 10(1-4):220-3. PubMed ID: 22205206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological mechanisms of Parkinson's disease].
    Matsui H; Takahashi R
    Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.
    Ohnuki T; Nakamura A; Okuyama S; Nakamura S
    Brain Res; 2010 Jul; 1346():26-42. PubMed ID: 20513370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes, proteins, and neurotoxins involved in Parkinson's disease.
    von Bohlen und Halbach O; Schober A; Krieglstein K
    Prog Neurobiol; 2004 Jun; 73(3):151-77. PubMed ID: 15236834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.
    Grünblatt E; Mandel S; Jacob-Hirsch J; Zeligson S; Amariglo N; Rechavi G; Li J; Ravid R; Roggendorf W; Riederer P; Youdim MB
    J Neural Transm (Vienna); 2004 Dec; 111(12):1543-73. PubMed ID: 15455214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.
    Di Napoli M; Shah IM; Stewart DA
    Expert Rev Neurother; 2007 Dec; 7(12):1693-729. PubMed ID: 18052765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
    Yamashita H; Matsumoto M
    Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.